CompanyScope

Bristol-Myers Squibb Company revenue by year

Tickers BMY, CELG-RI · SEC CIK 14272 · Latest fiscal year ended Dec 31, 2025

Over the 10 fiscal years shown, revenue went from $19.43B (year ended Dec 31, 2016) to $48.19B (year ended Dec 31, 2025), a compound annual growth rate of 10.6%. The fastest growth was +62.6% in the year ended Dec 31, 2020; the weakest year was −2.5% (year ended Dec 31, 2023).

$0$20B$40B$60BDec 2016: $19.43BDec 2017: $20.78BDec 2018: $22.56BDec 2019: $26.14BDec 2020: $42.52BDec 2021: $46.38BDec 2022: $46.16BDec 2023: $45.01BDec 2024: $48.30BDec 2025: $48.19BDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Bristol-Myers Squibb Company revenue by fiscal year, USD. Hover a bar for the exact figure.

Annual revenue

Fiscal year endedRevenue (USD)ChangeXBRL conceptReported in
Dec 31, 2025$48.19B−0.2%Revenues10-K filed Feb 11, 2026
Dec 31, 2024$48.30B+7.3%Revenues10-K filed Feb 11, 2026
Dec 31, 2023$45.01B−2.5%Revenues10-K filed Feb 11, 2026
Dec 31, 2022$46.16B−0.5%Revenues10-K filed Feb 12, 2025
Dec 31, 2021$46.38B+9.1%Revenues10-K filed Feb 13, 2024
Dec 31, 2020$42.52B+62.6%Revenues10-K filed Feb 14, 2023
Dec 31, 2019$26.14B+15.9%Revenues10-K filed Feb 9, 2022
Dec 31, 2018$22.56B+8.6%Revenues10-K filed Feb 10, 2021
Dec 31, 2017$20.78B+6.9%Revenues10-K filed Feb 24, 2020
Dec 31, 2016$19.43B+17.3%Revenues10-K filed Feb 25, 2019

Quarterly revenue

Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.

QuarterRevenue (USD)vs same quarter a year earlierSource
3 months ended Sep 30, 2026$13.07B+6.9%10-Q filed Oct 29, 2026
3 months ended Jun 30, 2026$12.97B+5.7%10-Q filed Jul 30, 2026
3 months ended Mar 31, 2026$11.49B+2.6%10-Q filed Apr 30, 2026
3 months ended Sep 30, 2025$12.22B+2.8%10-Q filed Oct 29, 2026
3 months ended Jun 30, 2025$12.27B+0.6%10-Q filed Jul 30, 2026
3 months ended Mar 31, 2025$11.20B−5.6%10-Q filed Apr 30, 2026
3 months ended Sep 30, 2024$11.89B+8.4%10-Q filed Oct 30, 2025
3 months ended Jun 30, 2024$12.20B+8.7%10-Q filed Jul 31, 2025

Source: SEC EDGAR XBRL company facts for CIK 14272 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.